Evaluation of Medicines Use Review in Slovenia

Summary

Medicines Use Review service (PUZ) has been officially introduced in Slovenian pharmacy practice in 2015 and has been offered to pharmacy customers by pharmacist, certified to provide the service. Patients can to talk to a pharmacist and discuss their medicines, how they use it and any issues or question they might have. We designed a study to evaluate how Medicines Use Review (PUZ) work and how it is reaching the set objectives. The objectives of the PUZ service are to address actual patient medicines use and consequently improve medication adherence, identify and solve drug related problems and enhance medication knowledge. Pharmacists, who are certified to provide the service, recognized the patients, who might need the service and invited them to participate in the study. The study consisted of two visits in 12 weeks' time period. Patients, who decided to participate, were randomly allocated in two groups - intervention and control. Both groups were interviewed and fulfilled questionnaires at visit 1 (V1). Afterwards the test group patients received PUZ. After 12 weeks both groups attended the visit 2 (V2), where they were re-interviewed and fulfilled questionnaires again. After the study completion also the patients from control group received PUZ due to ethical reasons.

Conditions

• Medicines Use Review Service
• Multiple Medication
• Adherence, Medication

Interventions

BEHAVIORAL

medicines use review

The provision of MUR service as defined in the SOP MUR (Slovene Chamber of Pharmacies). It is classified as a type 2a review (PCNE typology) and it is intended for the patients to support them in regular and proper medicines use. MUR is performed based on medication history and information provided by the patient in a purposely scheduled conversation with the pharmacist. Pharmacists must be certified to provide MUR. MUR goal is to identify DRPs and recommend interventions to resolve them. During the MUR interview, the pharmacist completes a working sheet that records information regarding medicines, identified DRPs and recommended interventions. After the MUR interview, patients are provided with a personal medicines card that contains all the information that is needed to support effective and safe medicines use (dosing regimen, taking with/without food, special warnings, recommendations, etc.).

Sponsors & Collaborators

• Comunity pharmacy Celjske lekarne

  collaborator UNKNOWN

• Comunity pharmacy Gorenjske lekarne

  collaborator UNKNOWN

• Comunity pharmacy Goriška lekarna Nova Gorica

  collaborator UNKNOWN

• Comunity pharmacy Javni zdravstveni zavod Mariborske lekarne Maribor

  collaborator UNKNOWN

• Comunity pharmacy Kraške lekarne Ilirska Bistrica

  collaborator UNKNOWN

• Comunity pharmacy Lekarna Brežice

  collaborator UNKNOWN

• Comunity pharmacy Lekarna Kočevje

  collaborator UNKNOWN

• Comunity pharmacy Lekarna Ljubljana

  collaborator UNKNOWN

• Comunity pharmacy Lekarna Ormož

  collaborator UNKNOWN

• Comunity pharmacy Lekarna Sevnica

  collaborator UNKNOWN

• Comunity pharmacy Lekarne Ptuj

  collaborator UNKNOWN

• Comunity pharmacy Obalne lekarne Koper

  collaborator UNKNOWN

• Comunity pharmacy Pomurske lekarne Murska Sobota

  collaborator UNKNOWN

• Comunity pharmacy Žalske lekarne Žalec

  collaborator UNKNOWN

• Mitja Kos

  lead OTHER

Principal Investigators

• Igor Locatelli, M.Pharm, PhD · University of Ljubljana

• Mitja Kos, MPharm, PhD · University of Ljubljana

• Urska Nabergoj Makovec, MPharm · University of Ljubljana

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-05-09

Primary Completion

2017-09-16

Completion

2017-09-16

Countries

• Slovenia

Study Locations